This is to inform you that pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), the audio recording and transcript of the Post Earnings (Conference) Call held on 3:30 PM of the 11th day of November 2022, has been made available at the Investor Presentations section of our website: Https://www.medplusindia.com/corporate.jsp
This is to inform you that pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), the audio recording and transcript of the Post Earnings (Conference) Call held on Thursday, August 11, 2022 has been made available on our website
We wish to inform you that the Company on 31st May, 2022, through Teleconference, conducted the Q4FY22 Earnings Con-Call with respect to the Audited Standalone and Consolidated Financial Results of the Company for the Fourth Quarter and Financial Year ended 31st March, 2022. The interactions used a Q&A format. The Investor Presentation referred was uploaded on the Stock Exchange(s) and Company's Website on 31st May, 2022.
This is further to our letter dated 14>> February 2022, wherein we had given you an advance intimation of the upcoming Analyst or Institutional Investor Interactions in terms of Regulation 30 read with Schedule II] of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. We wish to inform you that the Company today i.e. on 16' February 2022, through Teleconference, conducted the Q3FY22 Earnings Con-Call with respect to the Unaudited Standalone and Consolidated Financial Results of the Company for the Third Quarter and Nine Months ended 31st December, 2021. The interactions used a Q&A format. The Investor Presentation referred was uploaded on the Stock Exchange(s) and Company''s Website on 15t February 2022.
